LB

Lonne Sol Britt

Lonne Sol-Britt


Professional Overview


Lonne Sol-Britt is an experienced venture capitalist with a proven track record of driving growth and innovation in the healthcare sector. As a VC at Landstinget Sörmland, she leverages her deep industry expertise and strategic acumen to identify and invest in promising healthcare technology startups.

Experience Summary



Current Role


As a VC at Landstinget Sörmland, Lonne is responsible for sourcing, evaluating, and managing investments in innovative healthcare companies. She works closely with portfolio organizations to provide strategic guidance, operational support, and access to a robust network of industry connections. Under her leadership, Landstinget Sörmland has established itself as a respected player in the Nordic venture capital landscape, supporting the development of groundbreaking healthcare solutions.

Career Progression


Prior to her current role, Lonne held various leadership positions within the healthcare industry, including serving as a Senior Consultant at Accenture and a Product Manager at Philips Healthcare. Her diverse experience, spanning both consulting and product development, has equipped her with a well-rounded understanding of the healthcare ecosystem and the unique challenges facing startups and established organizations alike.

Academic Background


Lonne holds a Master of Science degree in Biomedical Engineering from the Royal Institute of Technology (KTH) in Stockholm, where she specialized in medical device innovation and development. Her academic achievements, combined with her industry expertise, have positioned her as a sought-after thought leader in the healthcare technology space.

Areas of Expertise


  • Healthcare technology and innovation

  • Venture capital investment and portfolio management

  • Strategic advisory and operational support for startups

  • Medical device product development and commercialization

  • Cross-functional collaboration and team leadership


Professional Impact


Throughout her career, Lonne has demonstrated a keen ability to identify and invest in transformative healthcare technologies. Under her guidance, several of Landstinget Sörmland's portfolio companies have achieved significant milestones, including successful product launches, regulatory approvals, and commercial partnerships. Lonne's deep industry knowledge and collaborative approach have been instrumental in driving the growth and impact of these innovative healthcare solutions.

Conclusion


Lonne Sol-Britt's extensive experience, industry expertise, and proven track record of success make her a valuable asset to the healthcare venture capital community. As she continues to lead Landstinget Sörmland's investment strategy and support its portfolio companies, Lonne is poised to play a pivotal role in shaping the future of healthcare technology and improving patient outcomes.